Dealing with heterogeneity of triple negative breast cancer: From luminal androgen receptor to mesenchimal stem like subtype

Date 28 September 2014
Event ESMO 2014
Session Targeting intrinsic subtypes of metastatic breast cancer: The spectrum of sensitivity to endocrine therapy
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer, Metastatic
Pathology/Molecular Biology
Presenter Javier Cortes Castan
Authors J. Cortes Castan
  • Breast Cancer Program, Vall d'Hebron University Hospital, 08035 - Barcelona/ES